Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Emerging melanoma vaccines

Jean-Claude Bystryn1

  • 1The Ronald O Perelman Dept of Dermatology, The Kaplan Comprehensive Cancer Center, New York University School of Medicine, New York, USA. bystryn@nyu.edu

Expert Opinion on Emerging Drugs
|July 2, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts.

Journal of the American Academy of Dermatology·2011
Same author

Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update.

Autoimmunity·2011
Same author

Serum levels of inhibitors of apoptotic proteins (IAPs) change with IVIg therapy in pemphigus.

The Journal of investigative dermatology·2011
Same author

Effect of intravenous immunoglobulin with or without cytotoxic drugs on pemphigus intercellular antibodies.

Journal of the American Academy of Dermatology·2010
Same author

Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid.

Medical hypotheses·2009
Same author

Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis.

Experimental dermatology·2009